Tobacco Line was Cirtran’s largest segment in fiscal 2025, bringing in $2.94M of $3.13M (94%).
| Segment | FY 2012 | FY 2013 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Salesrevenuenet | — | — | ||
| Tobacco Line | $1.06M | $2.94M | ||
| All Other Product Line | $239.93K | $189.20K | ||
| Total | $1.30M | $3.13M |
Cirtran brought in $3.13M from its two segments in fiscal 2025, the year ended December 31, 2025. That was up 141.1% from $1.30M in fiscal 2024. Tobacco Line was the largest at $2.94M (93.9%), ahead of All Other Product Line at $189.20K (6.1%).
Compared with fiscal 2024, Tobacco Line grew 178.0% to $2.94M, while All Other Product Line fell 21.1% to $189.20K.
Cirtran (CIRX) reports its revenue by segment. In fiscal 2025, Tobacco Line was its largest segment, bringing in $2.94M (93.9% of the total), followed by All Other Product Line at $189.20K (6.1%).
Tobacco Line was Cirtran's largest segment in fiscal 2025, bringing in $2.94M, or 93.9% of the $3.13M total across its two segments.
Tobacco Line grew faster than All Other Product Line in fiscal 2025, up 178.0% from $1.06M to $2.94M. All Other Product Line fell 21.1% to $189.20K.
Every figure comes from Cirtran's annual financial filings, as reported. Each line keeps the name Cirtran gives it, and years follow its fiscal calendar.
Cirtran's revenue by segment goes back to fiscal 2012, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.